Cargando…
The effectiveness and value of targeted immune modulators for moderate to severe ulcerative colitis: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum
Autores principales: | Pandey, Rajshree, Ollendorf, Daniel A, Fazioli, Katherine, Bloudek, Lisa, Carlson, Josh J, Pearson, Steven D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391273/ https://www.ncbi.nlm.nih.gov/pubmed/33645245 http://dx.doi.org/10.18553/jmcp.2021.27.3.405 |
Ejemplares similares
-
Optimal treatment sequence for targeted immune modulators for the treatment of moderate to severe ulcerative colitis
por: Bloudek, Lisa M, et al.
Publicado: (2021) -
The effectiveness and value of aducanumab for Alzheimer’s disease: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum
por: Synnott, Patricia G, et al.
Publicado: (2021) -
Mavacamten for hypertrophic cardiomyopathy: effectiveness and value: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum
por: Beinfeld, Molly, et al.
Publicado: (2022) -
The Effectiveness and Value of Siponimod for Secondary Progressive Multiple Sclerosis: A Summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council
por: Synnott, Patricia G., et al.
Publicado: (2020) -
The effectiveness and value of tezepelumab for severe asthma: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum
por: Rind, David M, et al.
Publicado: (2022)